We are live on ! Find out more

15 hedge funds and large institutions have $403K invested in Imunon in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0.34%0.34% (+0%)

6% less funds holding

Funds holding: 1615 (-1)

22% less capital invested

Capital invested by funds: $515K → $403K (-$112K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q3 2023 in Review

15 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2023, worth a combined $403K — down 22% from $515K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of IMNN and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.

The largest buyer was Geode Capital Management, adding an estimated $21.2K. The largest seller was BlackRock, cutting an estimated $10.3K.

  • 15 institutional investors held Imunon (IMNN) as of Q3 2023, down from 16 in Q2 2023.
  • Funds reported $403K of Imunon stock for Q3 2023, down 22% quarter-over-quarter.
  • 1 fund opened new Imunon positions in Q3 2023 and 2 closed out, a net change of -1 holder.
  • The largest Imunon buyer in Q3 2023 was Geode Capital Management, an estimated $21.2K added.
  • The largest Imunon seller in Q3 2023 was BlackRock, an estimated $10.3K sold.

Based on aggregated 13F filings for Q3 2023.